EFFICACY, SAFETY AND TOLERABILITY OF RACLOPRIDE, A SPECIFIC D2-RECEPTOR BLOCKER, IN ACUTE SCHIZOPHRENIA - AN OPEN TRIAL

被引：26

作者：

COOKSON, JC ^{[1
]}

NATORF, B ^{[1
]}

HUNT, N ^{[1
]}

SILVERSTONE, T ^{[1
]}

UPPFELDT, G ^{[1
]}

机构：

[1] LONDON HOSP,ST BARTHOLOMEW MED COLL,ACAD UNIT HUMAN PSYCHOPHARMACOL,LONDON E3 4LL,ENGLAND

来源：

关键词：

D O I：

10.1097/00004850-198901000-00007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：61 / 70

页数：10

共 18 条

[11] STANDARDIZED PSYCHIATRIC-ASSESSMENT SCALE FOR RATING CHRONIC PSYCHOTIC-PATIENTS
KRAWIECKA, M
GOLDBERG, D
VAUGHAN, M
[J]. ACTA PSYCHIATRICA SCANDINAVICA, 1977, 55 (04) : 299 - 308
[12] MONTGOMERY SA, 1978, NEUROPHARMACOLOGY, P1061
[13] OGREN SO, 1986, PSYCHOPHARMACOLOGY, V90, P287
[14] OVERALL JE, 1962, PSYCHOL REP, V10, P799
[15] Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11
[16] PROLACTIN RESPONSE FOLLOWING INTRAVENOUS AND ORAL SULPIRIDE IN HEALTHY-HUMAN SUBJECTS IN RELATION TO SULPIRIDE CONCENTRATIONS
WIESEL, FA
ALFREDSSON, G
EHRNEBO, M
SEDVALL, G
[J]. PSYCHOPHARMACOLOGY, 1982, 76 (01) : 44 - 47
[17] 1976, EDCEU MANUAL
[18] ABNORMAL INVOLUNTARY